Polyethylenimine nanoparticles as an efficient in vitro siRNA delivery system

Area of Science:

• Biotechnology
• Molecular Biology
• Nanomedicine

Background:

• RNA interference (RNAi) is a potent gene silencing mechanism utilizing small interfering RNA (siRNA).
• siRNA holds therapeutic potential for various diseases and serves as a research tool for gene function studies.
• Efficient delivery of siRNA into mammalian cells is crucial for its therapeutic and research applications.

Purpose of the Study:

• To investigate the potential of polyethylenimine (PEI) nanoparticles for siRNA delivery into mammalian cells.
• To characterize the physical properties and siRNA complexation of PEI nanoparticles.
• To evaluate the gene silencing efficiency and cytotoxicity of PEI nanoparticles compared to a commercial agent.

Main Methods:

• PEI nanoparticles were synthesized via acylation with propionic anhydride and cross-linking with polyethylene glycol-bis(phosphate).
• Nanoparticle size and morphology were analyzed using Dynamic Light Scattering (DLS) and Atomic Force Microscopy (AFM).
• siRNA delivery efficiency was assessed using siRNA targeting the green fluorescent protein (GFP) gene, and gene silencing was quantified.

Main Results:

• PEI nanoparticles exhibited an average size of approximately 100-110 nm, appearing spherical and compact.
• Higher concentrations of PEI nanoparticles were required for siRNA electro-neutralization compared to native PEI.
• PEI nanoparticles achieved gene silencing efficiency comparable to the commercial agent Lipofectin, with significantly reduced cytotoxicity.

Conclusions:

• Synthesized PEI nanoparticles are effective carriers for siRNA delivery in mammalian cells.
• PEI nanoparticles offer a promising alternative to existing transfection agents due to comparable efficacy and lower toxicity.
• This study highlights the potential of PEI-based nanoparticles for advancing siRNA-based therapeutics and research.